nodes	percent_of_prediction	percent_of_DWPC	metapath
Guanfacine—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.172	0.269	CbGbCtD
Guanfacine—CYP2C19—Progesterone—uterine cancer	0.137	0.214	CbGbCtD
Guanfacine—CYP2C9—Progesterone—uterine cancer	0.114	0.178	CbGbCtD
Guanfacine—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0999	0.156	CbGbCtD
Guanfacine—CYP3A4—Progesterone—uterine cancer	0.0662	0.104	CbGbCtD
Guanfacine—CYP3A4—Etoposide—uterine cancer	0.0296	0.0464	CbGbCtD
Guanfacine—CYP3A4—Doxorubicin—uterine cancer	0.0202	0.0316	CbGbCtD
Guanfacine—NISCH—Podofilox—Etoposide—uterine cancer	0.00889	1	CbGdCrCtD
Guanfacine—Diclofenac—CXCL8—uterine cancer	0.00332	1	CrCbGaD
Guanfacine—NISCH—uterine cervix—uterine cancer	0.00203	0.0945	CbGeAlD
Guanfacine—NISCH—smooth muscle tissue—uterine cancer	0.00198	0.0918	CbGeAlD
Guanfacine—NISCH—decidua—uterine cancer	0.00194	0.09	CbGeAlD
Guanfacine—NISCH—mammalian vulva—uterine cancer	0.00178	0.0826	CbGeAlD
Guanfacine—NISCH—uterus—uterine cancer	0.0017	0.0787	CbGeAlD
Guanfacine—NISCH—female gonad—uterine cancer	0.00139	0.0644	CbGeAlD
Guanfacine—NISCH—vagina—uterine cancer	0.00138	0.064	CbGeAlD
Guanfacine—Fatigue—Progesterone—uterine cancer	0.00097	0.00296	CcSEcCtD
Guanfacine—Constipation—Progesterone—uterine cancer	0.000962	0.00294	CcSEcCtD
Guanfacine—ADRA2A—myometrium—uterine cancer	0.000953	0.0442	CbGeAlD
Guanfacine—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.000953	0.00291	CcSEcCtD
Guanfacine—Atrioventricular block—Epirubicin—uterine cancer	0.000932	0.00284	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000929	0.00283	CcSEcCtD
Guanfacine—Feeling abnormal—Progesterone—uterine cancer	0.000927	0.00283	CcSEcCtD
Guanfacine—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.000922	0.00281	CcSEcCtD
Guanfacine—Gastrointestinal pain—Progesterone—uterine cancer	0.00092	0.00281	CcSEcCtD
Guanfacine—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.000916	0.00279	CcSEcCtD
Guanfacine—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.000909	0.00277	CcSEcCtD
Guanfacine—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.000906	0.00277	CcSEcCtD
Guanfacine—Ill-defined disorder—Dactinomycin—uterine cancer	0.000904	0.00276	CcSEcCtD
Guanfacine—Nocturia—Doxorubicin—uterine cancer	0.000902	0.00275	CcSEcCtD
Guanfacine—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.000898	0.00274	CcSEcCtD
Guanfacine—NISCH—lymph node—uterine cancer	0.000892	0.0414	CbGeAlD
Guanfacine—Acute coronary syndrome—Etoposide—uterine cancer	0.00089	0.00271	CcSEcCtD
Guanfacine—Abdominal pain—Progesterone—uterine cancer	0.00089	0.00271	CcSEcCtD
Guanfacine—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.000886	0.0027	CcSEcCtD
Guanfacine—Myocardial infarction—Etoposide—uterine cancer	0.000885	0.0027	CcSEcCtD
Guanfacine—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.000879	0.00268	CcSEcCtD
Guanfacine—Malaise—Dactinomycin—uterine cancer	0.000879	0.00268	CcSEcCtD
Guanfacine—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.000872	0.00266	CcSEcCtD
Guanfacine—Skin exfoliation—Epirubicin—uterine cancer	0.000863	0.00263	CcSEcCtD
Guanfacine—Atrioventricular block—Doxorubicin—uterine cancer	0.000863	0.00263	CcSEcCtD
Guanfacine—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00084	0.00256	CcSEcCtD
Guanfacine—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.000834	0.00254	CcSEcCtD
Guanfacine—Cramps of lower extremities—Epirubicin—uterine cancer	0.000831	0.00254	CcSEcCtD
Guanfacine—Myalgia—Dactinomycin—uterine cancer	0.00083	0.00253	CcSEcCtD
Guanfacine—Hypersensitivity—Progesterone—uterine cancer	0.000829	0.00253	CcSEcCtD
Guanfacine—Discomfort—Dactinomycin—uterine cancer	0.00082	0.0025	CcSEcCtD
Guanfacine—Asthenia—Progesterone—uterine cancer	0.000807	0.00246	CcSEcCtD
Guanfacine—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000806	0.00246	CcSEcCtD
Guanfacine—Skin exfoliation—Doxorubicin—uterine cancer	0.000799	0.00244	CcSEcCtD
Guanfacine—Pruritus—Progesterone—uterine cancer	0.000796	0.00243	CcSEcCtD
Guanfacine—Oedema—Dactinomycin—uterine cancer	0.000795	0.00243	CcSEcCtD
Guanfacine—Diarrhoea—Progesterone—uterine cancer	0.00077	0.00235	CcSEcCtD
Guanfacine—Cramps of lower extremities—Doxorubicin—uterine cancer	0.000769	0.00235	CcSEcCtD
Guanfacine—Eye disorder—Etoposide—uterine cancer	0.000757	0.00231	CcSEcCtD
Guanfacine—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000751	0.00229	CcSEcCtD
Guanfacine—Dizziness—Progesterone—uterine cancer	0.000744	0.00227	CcSEcCtD
Guanfacine—ADRA2A—uterine cervix—uterine cancer	0.000742	0.0344	CbGeAlD
Guanfacine—Vascular purpura—Epirubicin—uterine cancer	0.000734	0.00224	CcSEcCtD
Guanfacine—Immune system disorder—Etoposide—uterine cancer	0.000732	0.00223	CcSEcCtD
Guanfacine—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000732	0.00223	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000725	0.00221	CcSEcCtD
Guanfacine—Cardiac failure congestive—Epirubicin—uterine cancer	0.000724	0.00221	CcSEcCtD
Guanfacine—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000721	0.0022	CcSEcCtD
Guanfacine—Alopecia—Etoposide—uterine cancer	0.000716	0.00218	CcSEcCtD
Guanfacine—Vomiting—Progesterone—uterine cancer	0.000715	0.00218	CcSEcCtD
Guanfacine—Renal failure acute—Epirubicin—uterine cancer	0.000711	0.00217	CcSEcCtD
Guanfacine—Rash—Progesterone—uterine cancer	0.000709	0.00216	CcSEcCtD
Guanfacine—Dermatitis—Progesterone—uterine cancer	0.000709	0.00216	CcSEcCtD
Guanfacine—ADRA2A—decidua—uterine cancer	0.000707	0.0328	CbGeAlD
Guanfacine—Headache—Progesterone—uterine cancer	0.000705	0.00215	CcSEcCtD
Guanfacine—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000698	0.00213	CcSEcCtD
Guanfacine—Dermatitis exfoliative—Epirubicin—uterine cancer	0.000696	0.00212	CcSEcCtD
Guanfacine—Decreased appetite—Dactinomycin—uterine cancer	0.000691	0.00211	CcSEcCtD
Guanfacine—Dysgeusia—Etoposide—uterine cancer	0.000691	0.00211	CcSEcCtD
Guanfacine—Fatigue—Dactinomycin—uterine cancer	0.000686	0.00209	CcSEcCtD
Guanfacine—Purpura—Epirubicin—uterine cancer	0.000681	0.00208	CcSEcCtD
Guanfacine—Vascular purpura—Doxorubicin—uterine cancer	0.000679	0.00207	CcSEcCtD
Guanfacine—Muscle spasms—Etoposide—uterine cancer	0.000678	0.00207	CcSEcCtD
Guanfacine—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000674	0.00206	CcSEcCtD
Guanfacine—ADRA2A—endometrium—uterine cancer	0.000671	0.0311	CbGeAlD
Guanfacine—Cerebrovascular accident—Epirubicin—uterine cancer	0.00067	0.00204	CcSEcCtD
Guanfacine—Lethargy—Epirubicin—uterine cancer	0.00067	0.00204	CcSEcCtD
Guanfacine—Cardiac failure congestive—Doxorubicin—uterine cancer	0.00067	0.00204	CcSEcCtD
Guanfacine—CYP2C19—vagina—uterine cancer	0.000669	0.0311	CbGeAlD
Guanfacine—Nausea—Progesterone—uterine cancer	0.000668	0.00204	CcSEcCtD
Guanfacine—Renal failure acute—Doxorubicin—uterine cancer	0.000658	0.00201	CcSEcCtD
Guanfacine—Pain in extremity—Epirubicin—uterine cancer	0.000656	0.002	CcSEcCtD
Guanfacine—Feeling abnormal—Dactinomycin—uterine cancer	0.000655	0.002	CcSEcCtD
Guanfacine—Ill-defined disorder—Etoposide—uterine cancer	0.000654	0.002	CcSEcCtD
Guanfacine—Gastrointestinal pain—Dactinomycin—uterine cancer	0.00065	0.00198	CcSEcCtD
Guanfacine—ADRA2A—mammalian vulva—uterine cancer	0.000649	0.0301	CbGeAlD
Guanfacine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000648	0.00198	CcSEcCtD
Guanfacine—Affect lability—Epirubicin—uterine cancer	0.000646	0.00197	CcSEcCtD
Guanfacine—Dermatitis exfoliative—Doxorubicin—uterine cancer	0.000644	0.00196	CcSEcCtD
Guanfacine—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000643	0.00196	CcSEcCtD
Guanfacine—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000642	0.00196	CcSEcCtD
Guanfacine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000639	0.00195	CcSEcCtD
Guanfacine—Malaise—Etoposide—uterine cancer	0.000636	0.00194	CcSEcCtD
Guanfacine—Vertigo—Etoposide—uterine cancer	0.000634	0.00193	CcSEcCtD
Guanfacine—Purpura—Doxorubicin—uterine cancer	0.00063	0.00192	CcSEcCtD
Guanfacine—Abdominal pain—Dactinomycin—uterine cancer	0.000629	0.00192	CcSEcCtD
Guanfacine—Loss of consciousness—Etoposide—uterine cancer	0.00062	0.00189	CcSEcCtD
Guanfacine—Cerebrovascular accident—Doxorubicin—uterine cancer	0.00062	0.00189	CcSEcCtD
Guanfacine—Lethargy—Doxorubicin—uterine cancer	0.00062	0.00189	CcSEcCtD
Guanfacine—ADRA2A—uterus—uterine cancer	0.000618	0.0287	CbGeAlD
Guanfacine—Convulsion—Etoposide—uterine cancer	0.000611	0.00186	CcSEcCtD
Guanfacine—Hypertension—Etoposide—uterine cancer	0.000609	0.00186	CcSEcCtD
Guanfacine—Pain in extremity—Doxorubicin—uterine cancer	0.000607	0.00185	CcSEcCtD
Guanfacine—Liver function test abnormal—Epirubicin—uterine cancer	0.000606	0.00185	CcSEcCtD
Guanfacine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000606	0.00185	CcSEcCtD
Guanfacine—Chest pain—Etoposide—uterine cancer	0.0006	0.00183	CcSEcCtD
Guanfacine—Orthostatic hypotension—Epirubicin—uterine cancer	0.0006	0.00183	CcSEcCtD
Guanfacine—Abdominal pain upper—Epirubicin—uterine cancer	0.0006	0.00183	CcSEcCtD
Guanfacine—Affect lability—Doxorubicin—uterine cancer	0.000598	0.00182	CcSEcCtD
Guanfacine—Discomfort—Etoposide—uterine cancer	0.000593	0.00181	CcSEcCtD
Guanfacine—Hypersensitivity—Dactinomycin—uterine cancer	0.000586	0.00179	CcSEcCtD
Guanfacine—Confusional state—Etoposide—uterine cancer	0.00058	0.00177	CcSEcCtD
Guanfacine—Alanine aminotransferase increased—Epirubicin—uterine cancer	0.000579	0.00177	CcSEcCtD
Guanfacine—CYP2C9—female reproductive system—uterine cancer	0.000574	0.0266	CbGeAlD
Guanfacine—Asthenia—Dactinomycin—uterine cancer	0.000571	0.00174	CcSEcCtD
Guanfacine—Asthma—Epirubicin—uterine cancer	0.000567	0.00173	CcSEcCtD
Guanfacine—Dysphagia—Epirubicin—uterine cancer	0.000567	0.00173	CcSEcCtD
Guanfacine—Tachycardia—Etoposide—uterine cancer	0.000562	0.00171	CcSEcCtD
Guanfacine—Liver function test abnormal—Doxorubicin—uterine cancer	0.000561	0.00171	CcSEcCtD
Guanfacine—Hyperhidrosis—Etoposide—uterine cancer	0.000556	0.0017	CcSEcCtD
Guanfacine—ADRA2A—female reproductive system—uterine cancer	0.000556	0.0258	CbGeAlD
Guanfacine—Orthostatic hypotension—Doxorubicin—uterine cancer	0.000555	0.00169	CcSEcCtD
Guanfacine—Abdominal pain upper—Doxorubicin—uterine cancer	0.000555	0.00169	CcSEcCtD
Guanfacine—CYP3A4—renal system—uterine cancer	0.000546	0.0254	CbGeAlD
Guanfacine—Diarrhoea—Dactinomycin—uterine cancer	0.000544	0.00166	CcSEcCtD
Guanfacine—Hypotension—Etoposide—uterine cancer	0.000538	0.00164	CcSEcCtD
Guanfacine—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.000536	0.00163	CcSEcCtD
Guanfacine—Asthma—Doxorubicin—uterine cancer	0.000525	0.0016	CcSEcCtD
Guanfacine—Dysphagia—Doxorubicin—uterine cancer	0.000525	0.0016	CcSEcCtD
Guanfacine—Pollakiuria—Epirubicin—uterine cancer	0.000524	0.0016	CcSEcCtD
Guanfacine—Paraesthesia—Etoposide—uterine cancer	0.000517	0.00158	CcSEcCtD
Guanfacine—Weight increased—Epirubicin—uterine cancer	0.000516	0.00158	CcSEcCtD
Guanfacine—Dyspnoea—Etoposide—uterine cancer	0.000513	0.00157	CcSEcCtD
Guanfacine—Somnolence—Etoposide—uterine cancer	0.000512	0.00156	CcSEcCtD
Guanfacine—Drowsiness—Epirubicin—uterine cancer	0.000506	0.00154	CcSEcCtD
Guanfacine—Vomiting—Dactinomycin—uterine cancer	0.000506	0.00154	CcSEcCtD
Guanfacine—ADRA2A—female gonad—uterine cancer	0.000506	0.0235	CbGeAlD
Guanfacine—ADRA2A—vagina—uterine cancer	0.000502	0.0233	CbGeAlD
Guanfacine—Rash—Dactinomycin—uterine cancer	0.000501	0.00153	CcSEcCtD
Guanfacine—Decreased appetite—Etoposide—uterine cancer	0.0005	0.00153	CcSEcCtD
Guanfacine—Fatigue—Etoposide—uterine cancer	0.000496	0.00151	CcSEcCtD
Guanfacine—Constipation—Etoposide—uterine cancer	0.000492	0.0015	CcSEcCtD
Guanfacine—Conjunctivitis—Epirubicin—uterine cancer	0.000492	0.0015	CcSEcCtD
Guanfacine—Sweating—Epirubicin—uterine cancer	0.000485	0.00148	CcSEcCtD
Guanfacine—Pollakiuria—Doxorubicin—uterine cancer	0.000485	0.00148	CcSEcCtD
Guanfacine—Weight increased—Doxorubicin—uterine cancer	0.000478	0.00146	CcSEcCtD
Guanfacine—Feeling abnormal—Etoposide—uterine cancer	0.000474	0.00145	CcSEcCtD
Guanfacine—Nausea—Dactinomycin—uterine cancer	0.000472	0.00144	CcSEcCtD
Guanfacine—Gastrointestinal pain—Etoposide—uterine cancer	0.000471	0.00144	CcSEcCtD
Guanfacine—Drowsiness—Doxorubicin—uterine cancer	0.000468	0.00143	CcSEcCtD
Guanfacine—Bradycardia—Epirubicin—uterine cancer	0.000462	0.00141	CcSEcCtD
Guanfacine—Rhinitis—Epirubicin—uterine cancer	0.000455	0.00139	CcSEcCtD
Guanfacine—Abdominal pain—Etoposide—uterine cancer	0.000455	0.00139	CcSEcCtD
Guanfacine—Conjunctivitis—Doxorubicin—uterine cancer	0.000455	0.00139	CcSEcCtD
Guanfacine—Sweating—Doxorubicin—uterine cancer	0.000449	0.00137	CcSEcCtD
Guanfacine—Visual impairment—Epirubicin—uterine cancer	0.000438	0.00134	CcSEcCtD
Guanfacine—CYP3A4—female reproductive system—uterine cancer	0.000437	0.0203	CbGeAlD
Guanfacine—Bradycardia—Doxorubicin—uterine cancer	0.000428	0.00131	CcSEcCtD
Guanfacine—Eye disorder—Epirubicin—uterine cancer	0.000424	0.0013	CcSEcCtD
Guanfacine—Hypersensitivity—Etoposide—uterine cancer	0.000424	0.00129	CcSEcCtD
Guanfacine—Tinnitus—Epirubicin—uterine cancer	0.000423	0.00129	CcSEcCtD
Guanfacine—Rhinitis—Doxorubicin—uterine cancer	0.000421	0.00129	CcSEcCtD
Guanfacine—Asthenia—Etoposide—uterine cancer	0.000413	0.00126	CcSEcCtD
Guanfacine—Immune system disorder—Epirubicin—uterine cancer	0.00041	0.00125	CcSEcCtD
Guanfacine—Pruritus—Etoposide—uterine cancer	0.000407	0.00124	CcSEcCtD
Guanfacine—Visual impairment—Doxorubicin—uterine cancer	0.000405	0.00124	CcSEcCtD
Guanfacine—Alopecia—Epirubicin—uterine cancer	0.000401	0.00122	CcSEcCtD
Guanfacine—Diarrhoea—Etoposide—uterine cancer	0.000394	0.0012	CcSEcCtD
Guanfacine—Eye disorder—Doxorubicin—uterine cancer	0.000393	0.0012	CcSEcCtD
Guanfacine—Tinnitus—Doxorubicin—uterine cancer	0.000392	0.0012	CcSEcCtD
Guanfacine—Tension—Epirubicin—uterine cancer	0.000388	0.00118	CcSEcCtD
Guanfacine—Dysgeusia—Epirubicin—uterine cancer	0.000387	0.00118	CcSEcCtD
Guanfacine—Nervousness—Epirubicin—uterine cancer	0.000384	0.00117	CcSEcCtD
Guanfacine—Dizziness—Etoposide—uterine cancer	0.000381	0.00116	CcSEcCtD
Guanfacine—Muscle spasms—Epirubicin—uterine cancer	0.00038	0.00116	CcSEcCtD
Guanfacine—Immune system disorder—Doxorubicin—uterine cancer	0.00038	0.00116	CcSEcCtD
Guanfacine—Vision blurred—Epirubicin—uterine cancer	0.000373	0.00114	CcSEcCtD
Guanfacine—Alopecia—Doxorubicin—uterine cancer	0.000371	0.00113	CcSEcCtD
Guanfacine—Ill-defined disorder—Epirubicin—uterine cancer	0.000367	0.00112	CcSEcCtD
Guanfacine—Vomiting—Etoposide—uterine cancer	0.000366	0.00112	CcSEcCtD
Guanfacine—Agitation—Epirubicin—uterine cancer	0.000363	0.00111	CcSEcCtD
Guanfacine—Rash—Etoposide—uterine cancer	0.000363	0.00111	CcSEcCtD
Guanfacine—Dermatitis—Etoposide—uterine cancer	0.000363	0.00111	CcSEcCtD
Guanfacine—Headache—Etoposide—uterine cancer	0.000361	0.0011	CcSEcCtD
Guanfacine—Tension—Doxorubicin—uterine cancer	0.000359	0.0011	CcSEcCtD
Guanfacine—Dysgeusia—Doxorubicin—uterine cancer	0.000358	0.00109	CcSEcCtD
Guanfacine—Malaise—Epirubicin—uterine cancer	0.000357	0.00109	CcSEcCtD
Guanfacine—Nervousness—Doxorubicin—uterine cancer	0.000355	0.00108	CcSEcCtD
Guanfacine—Vertigo—Epirubicin—uterine cancer	0.000355	0.00108	CcSEcCtD
Guanfacine—Syncope—Epirubicin—uterine cancer	0.000355	0.00108	CcSEcCtD
Guanfacine—Muscle spasms—Doxorubicin—uterine cancer	0.000352	0.00107	CcSEcCtD
Guanfacine—Palpitations—Epirubicin—uterine cancer	0.000349	0.00107	CcSEcCtD
Guanfacine—Loss of consciousness—Epirubicin—uterine cancer	0.000347	0.00106	CcSEcCtD
Guanfacine—Vision blurred—Doxorubicin—uterine cancer	0.000345	0.00105	CcSEcCtD
Guanfacine—Convulsion—Epirubicin—uterine cancer	0.000343	0.00105	CcSEcCtD
Guanfacine—Nausea—Etoposide—uterine cancer	0.000342	0.00104	CcSEcCtD
Guanfacine—Hypertension—Epirubicin—uterine cancer	0.000341	0.00104	CcSEcCtD
Guanfacine—Ill-defined disorder—Doxorubicin—uterine cancer	0.000339	0.00104	CcSEcCtD
Guanfacine—Arthralgia—Epirubicin—uterine cancer	0.000337	0.00103	CcSEcCtD
Guanfacine—Myalgia—Epirubicin—uterine cancer	0.000337	0.00103	CcSEcCtD
Guanfacine—Chest pain—Epirubicin—uterine cancer	0.000337	0.00103	CcSEcCtD
Guanfacine—Agitation—Doxorubicin—uterine cancer	0.000336	0.00103	CcSEcCtD
Guanfacine—Anxiety—Epirubicin—uterine cancer	0.000335	0.00102	CcSEcCtD
Guanfacine—Discomfort—Epirubicin—uterine cancer	0.000333	0.00101	CcSEcCtD
Guanfacine—Malaise—Doxorubicin—uterine cancer	0.00033	0.00101	CcSEcCtD
Guanfacine—Dry mouth—Epirubicin—uterine cancer	0.000329	0.001	CcSEcCtD
Guanfacine—Vertigo—Doxorubicin—uterine cancer	0.000329	0.001	CcSEcCtD
Guanfacine—Syncope—Doxorubicin—uterine cancer	0.000328	0.001	CcSEcCtD
Guanfacine—Confusional state—Epirubicin—uterine cancer	0.000325	0.000993	CcSEcCtD
Guanfacine—ADRA2A—lymph node—uterine cancer	0.000325	0.0151	CbGeAlD
Guanfacine—Palpitations—Doxorubicin—uterine cancer	0.000323	0.000986	CcSEcCtD
Guanfacine—Oedema—Epirubicin—uterine cancer	0.000323	0.000985	CcSEcCtD
Guanfacine—Loss of consciousness—Doxorubicin—uterine cancer	0.000322	0.000981	CcSEcCtD
Guanfacine—Shock—Epirubicin—uterine cancer	0.000317	0.000969	CcSEcCtD
Guanfacine—Convulsion—Doxorubicin—uterine cancer	0.000317	0.000967	CcSEcCtD
Guanfacine—Hypertension—Doxorubicin—uterine cancer	0.000316	0.000964	CcSEcCtD
Guanfacine—Tachycardia—Epirubicin—uterine cancer	0.000315	0.000961	CcSEcCtD
Guanfacine—Hyperhidrosis—Epirubicin—uterine cancer	0.000312	0.000952	CcSEcCtD
Guanfacine—Chest pain—Doxorubicin—uterine cancer	0.000311	0.00095	CcSEcCtD
Guanfacine—Arthralgia—Doxorubicin—uterine cancer	0.000311	0.00095	CcSEcCtD
Guanfacine—Myalgia—Doxorubicin—uterine cancer	0.000311	0.00095	CcSEcCtD
Guanfacine—Anxiety—Doxorubicin—uterine cancer	0.00031	0.000947	CcSEcCtD
Guanfacine—Discomfort—Doxorubicin—uterine cancer	0.000308	0.000939	CcSEcCtD
Guanfacine—Dry mouth—Doxorubicin—uterine cancer	0.000305	0.000929	CcSEcCtD
Guanfacine—Hypotension—Epirubicin—uterine cancer	0.000301	0.00092	CcSEcCtD
Guanfacine—Confusional state—Doxorubicin—uterine cancer	0.000301	0.000919	CcSEcCtD
Guanfacine—Oedema—Doxorubicin—uterine cancer	0.000299	0.000911	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000294	0.000897	CcSEcCtD
Guanfacine—Shock—Doxorubicin—uterine cancer	0.000294	0.000896	CcSEcCtD
Guanfacine—Insomnia—Epirubicin—uterine cancer	0.000292	0.00089	CcSEcCtD
Guanfacine—Tachycardia—Doxorubicin—uterine cancer	0.000291	0.000889	CcSEcCtD
Guanfacine—Paraesthesia—Epirubicin—uterine cancer	0.00029	0.000884	CcSEcCtD
Guanfacine—Hyperhidrosis—Doxorubicin—uterine cancer	0.000289	0.000881	CcSEcCtD
Guanfacine—Dyspnoea—Epirubicin—uterine cancer	0.000288	0.000878	CcSEcCtD
Guanfacine—Somnolence—Epirubicin—uterine cancer	0.000287	0.000875	CcSEcCtD
Guanfacine—Dyspepsia—Epirubicin—uterine cancer	0.000284	0.000867	CcSEcCtD
Guanfacine—Decreased appetite—Epirubicin—uterine cancer	0.00028	0.000856	CcSEcCtD
Guanfacine—Hypotension—Doxorubicin—uterine cancer	0.000279	0.000851	CcSEcCtD
Guanfacine—Fatigue—Epirubicin—uterine cancer	0.000278	0.000849	CcSEcCtD
Guanfacine—Constipation—Epirubicin—uterine cancer	0.000276	0.000842	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000272	0.00083	CcSEcCtD
Guanfacine—Insomnia—Doxorubicin—uterine cancer	0.00027	0.000824	CcSEcCtD
Guanfacine—Paraesthesia—Doxorubicin—uterine cancer	0.000268	0.000818	CcSEcCtD
Guanfacine—Dyspnoea—Doxorubicin—uterine cancer	0.000266	0.000812	CcSEcCtD
Guanfacine—Feeling abnormal—Epirubicin—uterine cancer	0.000266	0.000811	CcSEcCtD
Guanfacine—Somnolence—Doxorubicin—uterine cancer	0.000265	0.00081	CcSEcCtD
Guanfacine—Gastrointestinal pain—Epirubicin—uterine cancer	0.000264	0.000805	CcSEcCtD
Guanfacine—Dyspepsia—Doxorubicin—uterine cancer	0.000263	0.000802	CcSEcCtD
Guanfacine—Decreased appetite—Doxorubicin—uterine cancer	0.00026	0.000792	CcSEcCtD
Guanfacine—Fatigue—Doxorubicin—uterine cancer	0.000257	0.000785	CcSEcCtD
Guanfacine—Constipation—Doxorubicin—uterine cancer	0.000255	0.000779	CcSEcCtD
Guanfacine—Abdominal pain—Epirubicin—uterine cancer	0.000255	0.000778	CcSEcCtD
Guanfacine—Feeling abnormal—Doxorubicin—uterine cancer	0.000246	0.000751	CcSEcCtD
Guanfacine—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000244	0.000745	CcSEcCtD
Guanfacine—Hypersensitivity—Epirubicin—uterine cancer	0.000238	0.000725	CcSEcCtD
Guanfacine—Abdominal pain—Doxorubicin—uterine cancer	0.000236	0.00072	CcSEcCtD
Guanfacine—Asthenia—Epirubicin—uterine cancer	0.000231	0.000706	CcSEcCtD
Guanfacine—Pruritus—Epirubicin—uterine cancer	0.000228	0.000697	CcSEcCtD
Guanfacine—Diarrhoea—Epirubicin—uterine cancer	0.000221	0.000674	CcSEcCtD
Guanfacine—Hypersensitivity—Doxorubicin—uterine cancer	0.00022	0.000671	CcSEcCtD
Guanfacine—Asthenia—Doxorubicin—uterine cancer	0.000214	0.000654	CcSEcCtD
Guanfacine—Dizziness—Epirubicin—uterine cancer	0.000213	0.000651	CcSEcCtD
Guanfacine—Pruritus—Doxorubicin—uterine cancer	0.000211	0.000645	CcSEcCtD
Guanfacine—Vomiting—Epirubicin—uterine cancer	0.000205	0.000626	CcSEcCtD
Guanfacine—Diarrhoea—Doxorubicin—uterine cancer	0.000204	0.000623	CcSEcCtD
Guanfacine—Rash—Epirubicin—uterine cancer	0.000203	0.000621	CcSEcCtD
Guanfacine—Dermatitis—Epirubicin—uterine cancer	0.000203	0.00062	CcSEcCtD
Guanfacine—Headache—Epirubicin—uterine cancer	0.000202	0.000617	CcSEcCtD
Guanfacine—Dizziness—Doxorubicin—uterine cancer	0.000197	0.000602	CcSEcCtD
Guanfacine—Nausea—Epirubicin—uterine cancer	0.000192	0.000585	CcSEcCtD
Guanfacine—Vomiting—Doxorubicin—uterine cancer	0.00019	0.000579	CcSEcCtD
Guanfacine—Rash—Doxorubicin—uterine cancer	0.000188	0.000574	CcSEcCtD
Guanfacine—Dermatitis—Doxorubicin—uterine cancer	0.000188	0.000574	CcSEcCtD
Guanfacine—Headache—Doxorubicin—uterine cancer	0.000187	0.000571	CcSEcCtD
Guanfacine—Nausea—Doxorubicin—uterine cancer	0.000177	0.000541	CcSEcCtD
